These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7865851)

  • 1. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.
    Bozzetti C; Nizzoli R; Naldi N; Manotti L; Savoldi L; Camisa R; Guazzi A; Cocconi G
    Breast Cancer Res Treat; 1994; 32(2):221-8. PubMed ID: 7865851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
    Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
    Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
    Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
    Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G
    Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
    Makris A; Allred DC; Powles TJ; Dowsett M; Fernando IN; Trott PA; Ashley SE; Ormerod MG; Titley JC; Osborne CK
    Breast Cancer Res Treat; 1997 May; 44(1):65-74. PubMed ID: 9164679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology.
    Cuthbert A; Herbert A; Coddington R; Theaker J; Taylor I; Royle GT
    Cytopathology; 1990; 1(6):339-47. PubMed ID: 2101680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fine-needle aspirates of breast cancers to evaluate hormone-receptor status.
    Lundy J; Lozowski M; Sadri D; Mishriki Y
    Arch Surg; 1990 Feb; 125(2):174-6. PubMed ID: 2302058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
    Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory reproducibility of the immunocytochemical assessment of oestrogen and progesterone receptors and proliferative activity in fine needle aspiration of breast cancer.
    Confortini M; Carozzi F; Bozzola L; Miccinesi G; Mirri F; Mottolese M; Noferini D; Nizzoli R; Tinacci G; Vocaturo A; Zappa M; Maddau C
    Cytopathology; 2002 Apr; 13(2):92-100. PubMed ID: 11952747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors.
    Weintraub J; Weintraub D; Redard M; Vassilakos P
    Cancer; 1987 Sep; 60(6):1163-72. PubMed ID: 3304609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
    Skoog L; Humla S; Isaksson S; Tani E
    Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
    Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
    Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.